There are better companies out there to join - Designer GoodRx Employee Review

1.0
Sep 9, 2022
Recommend
CEO approval
Business Outlook

Pros

Take care of yourself days were nice. Just extra company holidays felt nice.

Cons

Many folks speak out about GoodRx being mission-oriented, which their original business idea around prescription coupons does help a lot of Americans and is extremely valuable. The issue is... that's it. Leadership is not customer-focused. They are basing their business decisions on whatever they come up with and that changes monthly, hence the numerous re-orgs. Instead, they should be understanding customer needs and creating solutions to those problems. This isn't a place where your opinions and ideas are valued. This is a place where you just do whatever leadership wants. It's extremely top-down. Also, work does not need to be this chaotic. It doesn't need to overwhelm you and stress you out. Work can be a good place for you to just do good work and also live your life outside of it. I felt extremely overwhelmed by the constant shuffling of the company and the decisions that the leadership team was making. Pay really isn't that competitive either.

Explore other reviews about GoodRx

5.0
May 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Great space to learn, encouraged learning from mistakes, great overall positive attitude and collaboration amongst eng and non-eng co-workers

Cons

Started to feel more of a company that started prioritizing profits and started to think of several products to ship out without much support for the reason or long term support to improve the products.

1
4.0
Jun 23, 2026
Recommend
CEO approval
Business Outlook

Pros

Great compensation and benefits. Extreme work flexibility. Mission driven work where you know your directly helping Americans access important health care. Company is taking a great measured approach to AI adoption.

Cons

GoodRx is an established dominant player in the prescription drug space and is starting to flounder a bit in the face of stiff, more digital first, competition. Unclear what the future holds and this is reflected in the stock price. As such project direction can be a bit vague. Similarly a long history of tech debt, further muddled by HIPAA requirements, can make product development painful.

See reviews by: Helpful|Rating|Date|All